Chemours Co
$ 18.02
-2.12%
25 Feb - close price
- Market Cap 2,701,053,000 USD
- Current Price $ 18.02
- High / Low $ 18.63 / 17.83
- Stock P/E N/A
- Book Value 1.67
- EPS -2.13
- Next Earning Report 2026-05-05
- Dividend Per Share $0.51
- Dividend Yield 2.79 %
- Next Dividend Date 2026-03-13
- ROA N/A %
- ROE -0.90 %
- 52 Week High 21.85
- 52 Week Low 9.01
About
The Chemours Company offers high performance chemicals in North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. The company is headquartered in Wilmington, Delaware.
Analyst Target Price
$18.89
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-05 | 2025-11-04 | 2025-08-05 | 2025-05-06 | 2025-02-18 | 2024-11-04 | 2024-08-01 | 2024-04-30 | 2024-03-27 | 2023-10-26 | 2023-07-27 | 2023-04-27 |
| Reported EPS | 0.05 | 0.2 | 0.58 | 0.13 | 0.11 | 0.4 | 0.38 | 0.32 | 0.31 | 0.63 | 1.1 | 0.98 |
| Estimated EPS | 0.0774 | 0.24 | 0.46 | 0.2 | 0.16 | 0.28 | 0.57 | 0.18 | 0.25 | 0.69 | 1.07 | 0.47 |
| Surprise | -0.0274 | -0.04 | 0.12 | -0.07 | -0.05 | 0.12 | -0.19 | 0.14 | 0.06 | -0.06 | 0.03 | 0.51 |
| Surprise Percentage | -35.4005% | -16.6667% | 26.087% | -35% | -31.25% | 42.8571% | -33.3333% | 77.7778% | 24% | -8.6957% | 2.8037% | 108.5106% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.2036 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-13 | 2025-12-15 | 2025-09-12 | 2025-06-16 | 2025-03-14 | 2024-12-16 | 2024-09-13 | 2024-06-14 | 2024-03-15 | 2023-12-15 |
| Amount | $0.0875 | $0.0875 | $0.0875 | $0.0875 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 |
Next Dividend Records
| Dividend per share (year): | $0.51 |
| Dividend Yield | 2.79% |
| Next Dividend Date | 2026-03-13 |
| Ex-Dividend Date | 2025-11-14 |
Recent News: CC
2026-02-26 01:53:14
This article analyzes Chemours (CC) stock valuation using discounted cash flow (DCF) and price-to-sales (P/S) ratios, concluding it is undervalued. The DCF model estimates a 63.6% discount, while the P/S ratio suggests it is inexpensive compared to industry peers and its proprietary "Fair Ratio." The article also presents "Bull" and "Bear" case narratives for Chemours, highlighting different future outlooks based on revenue growth, PFAS legal risks, and market expectations.
2026-02-25 17:53:14
The Goldman Sachs Group has raised its price target for Chemours (NYSE:CC) to $18.00 from $14.00, maintaining a "neutral" rating, which aligns with the industry's consensus. This adjustment follows Chemours exceeding Q4 EPS estimates, though the company continues to report a negative net margin and P/E ratio. Institutional ownership remains high, with several firms increasing their stakes, indicating continued interest despite mixed analyst sentiment.
2026-02-25 13:53:14
The average one-year price target for Chemours (NYSE:CC) has been increased by 14.03% to $19.00 per share, up from $16.66. This new target is 3.19% higher than its latest closing price of $18.41. The article also notes a decrease in institutional ownership and a bullish put/call ratio for CC.
2026-02-25 10:52:57
Chemours has signed a joint development agreement with French server manufacturer 2CRSi to formalize their collaboration on two-phase immersion cooling technology. This partnership follows successful testing of Chemours' Opteon 2P50 fluid with 2CRSi's servers, aiming to accelerate the development and deployment of advanced cooling solutions for high-density IT infrastructure, especially for AI and next-generation chips. Opteon 2P50 is highlighted for its environmental benefits, energy efficiency, and compatibility with IT components.
2026-02-24 21:52:57
The Chemours Company and 2CRSi have announced a Joint Development Agreement following the successful qualification of Chemours' Opteon™ two-phase immersion cooling fluid in 2CRSi servers. This partnership aims to accelerate the development and deployment of advanced two-phase cooling technologies for high-density IT infrastructure, especially for AI and next-generation chips. It is expected to significantly reduce energy and water consumption in data centers, offering a more efficient and sustainable approach to computing.
2026-02-24 18:52:57
BMO Capital analyst John McNulty reiterated a Buy rating on Chemours Company (CC) with a $19.00 price target, noting his historical success in the Basic Materials sector. Mizuho Securities also issued a Buy rating, while Morgan Stanley maintained a Hold rating on the stock. Chemours Company recently reported a quarterly revenue of $1.33 billion and a GAAP net loss of $61 million.
